Vicis, Inc.
SEATTLE, WA · Founded 2014 · CIK 0001608939 · Medtech · Private
Advanced helmets with protective padding technology designed to reduce head impact forces
vicis.co →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $67M
- 10 Form D · Nov 2019
- 83 months since last filing
- Contracts
- $141K
- 2 awards · Defense, Homeland Security
- #493 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20132014201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $3,011,322 | |
| Private capital raised | Form D · SEC | $4,047,571 | |
| Private capital raised | Form D · SEC | $3,955,000 | |
| Private capital raised | Form D · SEC | $1,245,000 | |
| Federal contract | Department of Defense · Research And Development | $130,552 | |
| Federal contract | Department of Homeland Security · High Impact Football Helmets. | $10,273 | |
| Private capital raised | Form D · SEC | $53,151,365 | |
| Private capital raised | Form D · SEC | $5,176,200 | |
| Private capital raised | Form D · SEC | $525,000 | |
| Private capital raised | Form D · SEC | $56,025 | |
| Private capital raised | Form D · SEC | $935,000 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 490 | CANTON BIOTECHNOLOGIES, INC. | $149K | — |
| 491 | Awarables, Inc. | $149K | $500K |
| 492 | CND LIFE SCIENCES, INC. | $146K | $19M |
| 493 | Vicis, Inc. | $141K | $67M |
| 494 | SOMARK INNOVATIONS INC | $140K | $300K |
| 495 | SYNAPSE BIOMEDICAL INC | $136K | $433K |
| 496 | GRAYMATTER RESEARCH | $135K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- David AucklandExecutive Officer
- William AyerDirector
- WILLIAM AYERDirector
- Samuel BrowdDirector · Executive Officer
- SAMUEL BROWDDirector · Executive Officer
- Lynnette FrankDirector
- Ralph GreeneDirector
- RALPH GREENEDirector
- David MarverDirector · Executive Officer
- DAVID MARVERDirector · Executive Officer
- Alan MontgomeryDirector
- ALAN MONTGOMERYDirector
- JONATHAN POSNERDirector · Executive Officer
- Per ReinhallDirector · Executive Officer
- PER REINHALLDirector · Executive Officer
- Frank WaltersDirector
- FRANK WALTERSDirector
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.